Skip to main content
. 2020 Jul 10;15(7):e0235599. doi: 10.1371/journal.pone.0235599

Table 2. Incidence rate of severe pneumothorax among patients who underwent percutaneous transthoracic needle biopsy of the lung.

Characteristics Total No. of events IR % (95% CI) Men No. of events IR % (95% CI) Women No. of events IR % (95% CI)
Total 56,509 1,145 2.4 (2.15, 2.73) 36,957 907 2.9 (2.55, 3.21) 19,552 238 1.4 (1.14, 1.69)
Age group
20–49 4,589 54 1.6 (1.11, 2.06) 2,321 26 1.5 (0.87, 2.17) 2,268 28 1.4 (0.88, 2.01)
50–59 10,170 142 1.6 (1.23, 1.93) 5,979 102 1.9 (1.48, 2.41) 4,191 40 1.0 (0.66, 1.25)
60–69 16,615 329 2.4 (2.02, 2.82) 11,450 276 2.9 (2.39, 3.33) 5,165 53 1.1 (0.75, 1.54)
70–79 19,741 485 2.7 (2.31, 3.02) 13,751 402 3.1 (2.68, 3.53) 5,990 83 1.5 (1.11, 1.92)
80+ 5,394 135 2.6 (2.05, 3.19) 3,456 101 3.1 (2.40, 3.89) 1,938 34 1.8 (1.09, 2.44)
Insurance status
Health insurance 52,876 1,050 2.4 (2.13, 2.71) 34,789 838 2.8 (2.51, 3.17) 18,087 212 1.4 (1.1, 1.67)
Medical Aid, VHS 3,633 95 2.6 (2.03, 3.18) 2,168 69 3.2 (2.37, 4.02) 1,465 26 1.7 (1.13, 2.36)
Guidancea
CT guidance 31,589 673 2.5 (2.13, 2.86) 20683 531 2.9 (2.48, 3.29) 10906 142 1.5 (1.09, 1.91)
Fluoroscopy guidance 18,724 331 2.1 (1.68, 2.50) 12,175 264 2.6 (2.02, 3.1) 6,549 67 1.2 (0.79, 1.59)
Year
2009 6,545 152 2.6 (2.04, 3.23) 4,350 116 2.9 (2.19, 3.56) 2,195 36 2.0 (1.12, 2.78)
2010 6,910 175 2.7 (2.13, 3.36) 4,611 146 3.4 (2.62, 4.09) 2,299 29 1.3 (0.76, 1.89)
2011 7,956 149 2.1 (1.61, 2.57) 5,205 122 2.6 (1.97, 3.14) 2,751 27 1.1 (0.61, 1.53)
2012 8,631 153 2.1 (1.63, 2.51) 5,556 123 2.5 (1.96, 3.05) 3,075 30 1.0 (0.63, 1.39)
2013 8,557 146 1.9 (1.51, 2.22) 5,543 108 2.1 (1.68, 2.61) 3,014 38 1.3 (0.84, 1.74)
2014 8,912 194 2.4 (1.86, 2.85) 5,801 157 2.9 (2.30, 3.49) 3,111 37 1.3 (0.75, 1.76)
2015 8,998 176 2.4 (1.87, 2.95) 5,891 135 2.7 (2.07, 3.37) 3,107 41 1.6 (0.93, 2.21)
Comorbidities
COPD 26,889 647 2.9 (2.53, 3.23) 18,828 534 3.4 (2.96, 3.79) 8,061 113 1.5 (1.17, 1.91)
PE 2,765 51 2.0 (1.38, 2.59) 1,801 39 2.4 (1.57, 3.18) 964 12 1.2 (0.57, 1.90)
CCI score
0 11,734 216 2.1 (1.68, 2.46) 7,162 166 2.5 (2.05, 3.02) 4,572 50 1.2 (0.77, 1.58)
1 11,200 242 2.3 (1.92, 2.75) 7,286 203 2.9 (2.41, 3.47) 3,914 39 1.1 (0.69, 1.45)
2 10,814 225 2.6 (2.12, 3.06) 6,919 170 2.9 (2.39, 3.48) 3,895 55 1.7 (1.14, 2.19)
3+ 22,761 462 2.3 (2.00, 2.69) 15,590 368 2.7 (2.31, 3.09) 7,171 94 1.4 (1.03, 1.83)
Lung surgery
Yes 1,113 14 1.6 (0.63, 2.54) 804 8 1.2 (0.28, 2.11) 309 6 2.2 (0.11, 4.38)
Region
Seoul metropolitan area 35,272 522 2.1 (1.74, 2.40) 22,559 409 2.4 (2.01, 2.70) 12,713 113 1.2 (0.86, 1.54)
Urban area 11,843 409 3.3 (2.70, 3.93) 7,898 323 4.0 (3.29, 4.71) 3,945 86 1.9 (1.35, 2.49)
Rural area 9,394 214 2.3 (1.79, 2.86) 6,500 175 2.8 (2.13, 3.45) 2,894 39 1.3 (0.83, 1.82)
Medical care institution
Superior general hospital 38,775 716 2.0 (1.65, 2.38) 25,208 571 2.5 (2.03, 2.90) 13,567 145 1.2 (0.82, 1.53)
General hospital 17,734 429 2.7 (2.33, 3.10) 11,749 336 3.2 (2.69, 3.64) 5,985 93 1.7 (1.30, 2.13)

IR: incidence rate, VHS: Veterans Health Service, CT: computed tomography, COPD: chronic obstructive pulmonary disease, PE: pleural effusion, CCI: Charlson Comorbidity Index.

a The categories of type of guidance were not mutually exclusive.